Pharmacological enhancement of neuroplasticity works—but only when combined with behavior, and the window is narrower than we thought

Ampakines, SSRIs, and BDNF mimetics can accelerate stroke recovery in animal models. Human trials have been disappointing. The problem is not the drugs—it is the delivery protocol. Neuroplasticity-enhancing compounds require active rehabilitation to work, and the optimal timing window may be weeks, not years.